| SANDRA LEUNG |
EVP, General Counsel |
$54,785,943 |
|
|
10 Mar 2025 |
| Giovanni Caforio |
Executive Chair of the Board, Director |
$26,671,063 |
|
|
10 Mar 2024 |
| CHRISTOPHER S. BOERNER |
Chief Executive Officer, Director |
$10,855,544 |
|
|
01 Nov 2025 |
| David Elkins V. |
EVP, Chief Financial Officer |
$9,851,249 |
-$2,650,480 |
-21% |
02 Sep 2025 |
| Samit Hirawat |
EVP,Chief Med.Offr.,Drug Dev. |
$5,835,958 |
+$202,215 |
+3.6% |
25 Apr 2025 |
| Gerald L. Storch |
Director |
$4,780,844 |
|
|
31 Mar 2024 |
| Peter J. Arduini |
Director |
$3,900,737 |
|
|
01 Feb 2026 |
| Theodore R. Samuels II |
Director |
$3,736,931 |
|
|
01 Feb 2026 |
| Paul von Autenried |
EVP, Chief Information Officer |
$3,162,825 |
|
|
22 Nov 2021 |
| Robert M. Plenge |
EVP, Chief Research Officer |
$3,094,569 |
|
|
10 Mar 2025 |
| Adam Lenkowsky |
EVP, Chief Commercial Officer |
$2,746,721 |
|
|
03 Nov 2025 |
| Gregory Scott Meyers |
EVP, Chief Digital & Tech Off. |
$2,662,378 |
|
|
01 Feb 2026 |
| Rupert Vessey |
EVP & President, Research |
$2,409,687 |
|
|
03 May 2023 |
| PHYLLIS R. YALE |
Director |
$2,385,134 |
|
|
01 Feb 2026 |
| Karen H. Vousden |
Director |
$2,260,865 |
|
|
01 Feb 2026 |
| Derica W. Rice |
Director |
$2,164,830 |
|
|
01 Feb 2026 |
| Benjamin Hickey |
President, RayzeBio Org. |
$2,097,565 |
-$3,702 |
-0.18% |
27 Feb 2026 |
| Julia A. Haller |
Director |
$2,086,568 |
|
|
01 Feb 2026 |
| Karin Shanahan |
EVP, Chief Supply Chain & Ops |
$2,074,128 |
|
|
01 Nov 2025 |
| Elizabeth Mily |
EVP, Strategy & BD |
$2,060,611 |
|
|
01 Apr 2023 |
| Phil M. Holzer |
SVP and Controller |
$1,875,077 |
|
|
10 Mar 2025 |
| Cari Gallman |
EVP, General Counsel |
$1,698,641 |
|
|
02 Oct 2025 |
| Louis S. Schmukler |
EVP,Pres.,Glob.Prod. & Supply |
$1,590,793 |
|
|
10 May 2021 |
| Paula A. Price |
Director |
$1,403,673 |
|
|
01 Feb 2026 |
| Ann Powell |
EVP, Chief Human Resources |
$1,387,273 |
|
|
24 Aug 2023 |
| Ahn Amanda Poole |
EVP, Chief People Officer |
$1,311,663 |
|
|
10 Mar 2025 |
| Medina Manuel Hidalgo |
Director |
$1,253,154 |
|
|
01 Feb 2026 |
| MICHAEL W. BONNEY |
Director |
$1,201,183 |
|
|
30 Jun 2021 |
| Deepak Bhatt |
Director |
$1,059,262 |
|
|
01 Feb 2026 |
| Karen Murphy Santiago |
SVP & Controller |
$1,006,074 |
|
|
14 Mar 2022 |
| Michael R. McMullen |
Director |
$824,631 |
|
|
01 Feb 2026 |
| Adam Dubow |
SVP,ChiefCompliance&EthicsOff. |
$734,207 |
|
|
30 Jul 2021 |
| Joseph Eid |
SVP,Head Glob. Medical Affairs |
$688,044 |
|
|
03 Jun 2021 |
| Lynelle Hoch |
President, Cell Therapy Org. |
$656,216 |
|
|
10 Mar 2025 |
| Michelle Weese |
EVP, Corporate Affairs |
$360,767 |
|
|
01 Jul 2023 |
| Bartie Wendy Short |
EVP, Corporate Affairs |
$267,463 |
-$16,719 |
-5.9% |
01 Sep 2025 |
| Sharon Greenlees |
SVP & Controller |
$190,798 |
|
|
02 May 2023 |
| Hiroshi Chris Shibutani |
EVP, Chief Strategy Officer |
|
|
|
01 Jul 2025 |
| Cristian Massacesi |
EVP,Chief Med Offr,Head of Dev |
|
|
|
01 Aug 2025 |